These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1364 related items for PubMed ID: 9265639

  • 21. Sialic acid moiety of apolipoprotein E3 at Thr(194) affects its interaction with beta-amyloid(1-42) peptides.
    Sugano M, Yamauchi K, Kawasaki K, Tozuka M, Fujita K, Okumura N, Ota H.
    Clin Chim Acta; 2008 Feb; 388(1-2):123-9. PubMed ID: 18023277
    [Abstract] [Full Text] [Related]

  • 22. Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms.
    Su KL, Wen TH, Chou CY, Chang GG, Liu GY, Hung HC.
    Proteins; 2007 Jul 01; 68(1):363-74. PubMed ID: 17410580
    [Abstract] [Full Text] [Related]

  • 23. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
    Wood SJ, Chan W, Wetzel R.
    Biochemistry; 1996 Sep 24; 35(38):12623-8. PubMed ID: 8823200
    [Abstract] [Full Text] [Related]

  • 24. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, Laska E, Ehrlich ME, Walker LC, Mathews PM, Gandy S.
    J Neurochem; 2004 Aug 24; 90(4):1011-8. PubMed ID: 15287908
    [Abstract] [Full Text] [Related]

  • 25. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T, Kawarabayashi T, Ueda T, Shimomura S, Hoshino M, Itoh K, Ihara K, Nakaji S, Takatama M, Ikeda Y, Shoji M.
    J Alzheimers Dis; 2023 Aug 24; 93(1):333-348. PubMed ID: 36970894
    [Abstract] [Full Text] [Related]

  • 26. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
    Cole GM, Ard MD.
    Microsc Res Tech; 2000 Aug 15; 50(4):316-24. PubMed ID: 10936886
    [Abstract] [Full Text] [Related]

  • 27. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB, Wilhelmus MM, Kox M, Veerhuis R, de Waal RM, Verbeek MM.
    Brain Res; 2010 Feb 22; 1315():169-80. PubMed ID: 20034483
    [Abstract] [Full Text] [Related]

  • 28. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S, Fioretti D, Mangialasche F, Rinaldi M.
    J Alzheimers Dis; 2010 Feb 22; 21(1):35-48. PubMed ID: 20182014
    [Abstract] [Full Text] [Related]

  • 29. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.
    Grootendorst J, Bour A, Vogel E, Kelche C, Sullivan PM, Dodart JC, Bales K, Mathis C.
    Behav Brain Res; 2005 Apr 15; 159(1):1-14. PubMed ID: 15794991
    [Abstract] [Full Text] [Related]

  • 30. Apolipoprotein E expression and purification.
    Newhouse Y, Weisgraber KH.
    Methods Mol Biol; 2011 Apr 15; 670():127-40. PubMed ID: 20967588
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA, Zhou B, Nabet AM, Wernig M, Südhof TC.
    J Neurosci; 2019 Sep 11; 39(37):7408-7427. PubMed ID: 31331998
    [Abstract] [Full Text] [Related]

  • 35. Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing.
    Biere AL, Ostaszewski B, Zhao H, Gillespie S, Younkin SG, Selkoe DJ.
    Neurobiol Dis; 1995 Jun 11; 2(3):177-87. PubMed ID: 9174001
    [Abstract] [Full Text] [Related]

  • 36. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.
    Moir RD, Atwood CS, Romano DM, Laurans MH, Huang X, Bush AI, Smith JD, Tanzi RE.
    Biochemistry; 1999 Apr 06; 38(14):4595-603. PubMed ID: 10194381
    [Abstract] [Full Text] [Related]

  • 37. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O, Dolev I, Belinson H, Michaelson DM.
    J Neurochem; 2007 Nov 06; 103(3):1031-40. PubMed ID: 17666042
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E.
    Tamamizu-Kato S, Cohen JK, Drake CB, Kosaraju MG, Drury J, Narayanaswami V.
    Biochemistry; 2008 May 06; 47(18):5225-34. PubMed ID: 18407659
    [Abstract] [Full Text] [Related]

  • 40. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes.
    DeKroon RM, Armati PJ.
    Neurobiol Dis; 2001 Feb 06; 8(1):78-89. PubMed ID: 11162242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 69.